Liminatus Pharma, Inc. Class A LIMN
NASDAQ · United States · Health Technology
$3.75+0.02 (+0.54%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Momentum and volatility snapshot
| Average | Value | Price vs. average |
|---|---|---|
| 20-period average | $3.73 | +0.44% · above |
| 50-period average | $4.68 | -19.89% · below |
| 200-period average | $14.62 | -74.34% · below |
| Avg. volume (1Y) | 266.54K |
Total return, dividends included.
All indicators are computed from the last year of daily closes. Returns and volatility use the dividend-adjusted series; averages and highs/lows use the traded price. Not investment advice.